Last Updated: June 24, 2026

List of Excipients in API lidocaine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing lidocaine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Endo USA Inc LIDOCAINE lidocaine 0603-1880 CARBOXYMETHYLCELLULOSE SODIUM
Endo USA Inc LIDOCAINE lidocaine 0603-1880 DIHYDROXYALUMINUM AMINOACETATE
Endo USA Inc LIDOCAINE lidocaine 0603-1880 EDETATE DISODIUM
Endo USA Inc LIDOCAINE lidocaine 0603-1880 GELATIN
Endo USA Inc LIDOCAINE lidocaine 0603-1880 GLYCERIN
Endo USA Inc LIDOCAINE lidocaine 0603-1880 KAOLIN
Endo USA Inc LIDOCAINE lidocaine 0603-1880 METHYLPARABEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing lidocaine

Company Ingredient NDC Excipient
Fougera Pharmaceuticals LLC lidocaine 0168-0204 POLYETHYLENE GLYCOL 1450
Fougera Pharmaceuticals LLC lidocaine 0168-0204 POLYETHYLENE GLYCOL 300
Septodont Inc lidocaine 0362-0221 POLYETHYLENE GLYCOL 1450
Septodont Inc lidocaine 0362-0221 POLYETHYLENE GLYCOL 300
Mylan Pharmaceuticals Inc lidocaine 0378-9055 POLYISOBUTYLENE
Liberty Pharmaceuticals Inc lidocaine 0440-9715 POLYETHYLENE GLYCOL 1450
Liberty Pharmaceuticals Inc lidocaine 0440-9715 POLYETHYLENE GLYCOL 300
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for lidocaine

Excipient focus: .ALPHA.-TOCOPHEROL, DL-

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM SILICATE

Excipient focus: ANHYDROUS CITRIC ACID

lidocaine drug variants containing ANHYDROUS CITRIC ACID

Company Ingredient NDC
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1232
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1419
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine 51662-1395
HF Acquisition Co LLC DBA HealthFirst lidocaine hcl and epinephrine 51662-1503
HF Acquisition Co LLC DBA HealthFirst lidocaine hcl and epinephrine 51662-1504
RPK Pharmaceuticals Inc lidocaine hydrochloride 53002-3432
Morton Grove Pharmaceuticals Inc lidocaine hydrochloride 60432-464
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

lidocaine drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Company Ingredient NDC
Taro Pharmaceuticals USA Inc lidocaine and tetracaine 51672-5305
SAE LLC lidocaine and tetracaine 69420-3077
IPG PHARMACEUTICALS INC lidocaine and tetracaine 71085-100
Innovida Pharmaceutique Corporation lidocaine and tetracaine 71800-631
Oba Pharmaceuticals Inc lidocaine and tetracaine 73575-009
Oba Pharmaceuticals Inc lidocaine and tetracaine 73575-010
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: AQUA

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

lidocaine drug variants containing CARBOMER HOMOPOLYMER TYPE B

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma lidocaine and prilocaine 0121-1002
E Fougera & Co a division of Fougera Pharmaceuticals Inc lidocaine and prilocaine 0168-0357
Padagis US LLC lidocaine and prilocaine 0574-2042
MAJOR Pharmaceuticals lidocaine and prilocaine 0904-6989
Encube Ethicals Inc lidocaine and prilocaine 21922-076
Aidarex Pharmaceuticals LLC lidocaine and prilocaine 33261-591
Rhodes Pharmaceuticals LP lidocaine and prilocaine 42858-029
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

lidocaine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc lidocaine hydrochloride 0054-3500
Xttrium Laboratories Inc lidocaine hydrochloride 0116-4027
Pharmaceutical Associates Inc lidocaine hydrochloride 0121-0903
PAI Holdings LLC dba PAI Pharma lidocaine hydrochloride 0121-0950
Lannett Company Inc lidocaine hydrochloride 0527-6002
Lannett Company Inc lidocaine hydrochloride 0527-6004
Actavis Pharma Inc lidocaine 0591-2679
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CARBOXYPOLYMETHYLENE

Excipient focus: CELLULOSE GUM

Excipient focus: CHERRY

Excipient focus: CITRIC ACID

Excipient focus: CITRIC ACID ANHYDROUS

Excipient focus: CITRIC ACID MONOHYDRATE

lidocaine drug variants containing CITRIC ACID MONOHYDRATE

Company Ingredient NDC
B Braun Medical Inc lidocaine hcl and epinephrine 0264-9378
A-S Medication Solutions lidocaine hydrochloride,epinephrine bitartrate 50090-3321
A-S Medication Solutions lidocaine hydrochloride,epinephrine bitartrate 50090-6851
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine with epinephrine 51662-1412
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine 51662-1505
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine 51662-1506
HF Acquisition Co LLC DBA HealthFirst lidocaine hcl and epi 51662-1589
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: DIETHYLENE GLYCOL MONOETHYL ETHER

Excipient focus: DIHYDROXYALUMINUM AMINOACETATE

Excipient focus: DIPROPYLENE GLYCOL

Excipient focus: EDETATE DISODIUM

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONO- AND DIPALMITOSTEARATE TYPE B

Excipient focus: HYDROCHLORIC ACID

lidocaine drug variants containing HYDROCHLORIC ACID

Company Ingredient NDC
Dentsply Pharmaceutical lidocaine and prilocaine 66312-110
HF Acquisition Co LLC DBA Health First lidocaine hci 51662-1230
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1232
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1233
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1364
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1382
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1384
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOSTEARIC ACID

Excipient focus: KAOLIN

Excipient focus: LACTIC ACID

Excipient focus: MALTODEXTRIN

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: OLEIC ACID

Excipient focus: ORANGE

lidocaine drug variants containing ORANGE

Company Ingredient NDC
STAT RX LLC USA lidocaine hydrochloride 16590-140
ATLANTIC BIOLOGICALS CORP lidocaine hydrochloride 17856-0775
Rebel Distributors Corp lidocaine hydrochloride 21695-783
LLC Federal Solutions lidocaine hydrochloride 24451-775
A-S Medication Solutions lidocaine hydrochloride 50090-0255
Akorn lidocaine hydrochloride 50383-775
Unit Dose Services lidocaine hydrochloride 50436-0775
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PEG-50 HYDROGENATED CASTOR OIL

Excipient focus: PEG-54 HYDROGENATED CASTOR OIL

lidocaine drug variants containing PEG-54 HYDROGENATED CASTOR OIL

Company Ingredient NDC
Rhodes Pharmaceuticals LP lidocaine and prilocaine 42858-029
Alembic Pharmaceuticals Limited lidocaine and prilocaine 46708-582
Alembic Pharmaceuticals Inc lidocaine and prilocaine 62332-582
Proficient Rx LP lidocaine and prilocaine 63187-577
Aleor Dermaceuticals Limited lidocaine and prilocaine 71589-017
TriRx Huntsville Pharmaceutical Services lidocaine and prilocaine cream 80432-053
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PEG-55 HYDROGENATED CASTOR OIL

lidocaine drug variants containing PEG-55 HYDROGENATED CASTOR OIL

Company Ingredient NDC
Actavis Pharma Inc lidocaine and prilocaine 0591-2070
DIRECT RX lidocaine and prilocaine 61919-443
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-825
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-826
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-828
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PEG-6

Excipient focus: PEG-60 HYDROGENATED CASTOR OIL

lidocaine drug variants containing PEG-60 HYDROGENATED CASTOR OIL

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma lidocaine and prilocaine 0121-1002
Padagis US LLC lidocaine and prilocaine 0574-2042
MAJOR Pharmaceuticals lidocaine and prilocaine 0904-6989
Encube Ethicals Inc lidocaine and prilocaine 21922-076
A-S Medication Solutions lidocaine and prilocaine 50090-2167
A-S Medication Solutions lidocaine and prilocaine 50090-6589
Teligent Pharma Inc lidocaine and prilocaine 52565-007
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PEPPERMINT OIL

Excipient focus: PETROLATUM

lidocaine drug variants containing PETROLATUM

Company Ingredient NDC
Taro Pharmaceuticals USA Inc lidocaine and tetracaine 51672-5305
SAE LLC lidocaine and tetracaine 69420-3077
IPG PHARMACEUTICALS INC lidocaine and tetracaine 71085-100
Innovida Pharmaceutique Corporation lidocaine and tetracaine 71800-631
Oba Pharmaceuticals Inc lidocaine and tetracaine 73575-009
Oba Pharmaceuticals Inc lidocaine and tetracaine 73575-010
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PHOSPHORIC ACID

Excipient focus: POLOXAMER 188

Excipient focus: POLOXAMER 407

Excipient focus: POLYACRYLIC ACID

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1450

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYISOBUTYLENE

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

lidocaine drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL

Company Ingredient NDC
Aidarex Pharmaceuticals LLC lidocaine and prilocaine 33261-591
Rebel Distributors Corp lidocaine and prilocaine 42254-195
Akorn lidocaine and prilocaine 50383-667
NuCare PharamceuticalsInc lidocaine and prilocaine 68071-1625
Accelis Pharma lidocaine and prilocaine 69166-105
Zydus Lifesciences Limited lidocaine and prilocaine 70771-1872
Viona Pharmaceuticals Inc lidocaine and prilocaine 72578-165
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYOXYL 60 HYDROGENATED CASTOR OIL

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM BISULFITE

Excipient focus: POTASSIUM METABISULFITE

lidocaine drug variants containing POTASSIUM METABISULFITE

Company Ingredient NDC
Septodont Inc lidocaine hydrochloride and epinephrine 0362-0262
Septodont Inc lidocaine hydrochloride and epinephrine 0362-0898
Septodont Inc lidocaine hydrochloride and epinephrine 0362-1095
Septodont Inc lidocaine hydrochloride and epinephrine 0362-1096
Septodont Inc lidocaine hydrochloride and epinephrine 0362-1200
Septodont lidocaine hydrochloride and epinephrine bitartrate 0362-9010
Septodont lidocaine hydrochloride and epinephrine bitartrate 0362-9023
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PROPYLENE CARBONATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

lidocaine drug variants containing SACCHARIN SODIUM

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc lidocaine hydrochloride 0054-3500
Xttrium Laboratories Inc lidocaine hydrochloride 0116-4027
Pharmaceutical Associates Inc lidocaine hydrochloride 0121-0903
PAI Holdings LLC dba PAI Pharma lidocaine hydrochloride 0121-0950
Lannett Company Inc lidocaine hydrochloride 0527-6002
Lannett Company Inc lidocaine hydrochloride 0527-6004
STAT RX LLC USA lidocaine hydrochloride 16590-140
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SERINE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

lidocaine drug variants containing SODIUM CHLORIDE

Company Ingredient NDC
HF Acquisition Co LLC DBA Health First lidocaine hci 51662-1230
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1232
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1233
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1364
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1384
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1416
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1419
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

lidocaine drug variants containing SODIUM HYDROXIDE

Company Ingredient NDC
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-825
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-826
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-828
Amneal Pharmaceuticals of New York LLC lidocaine and prilocaine 0115-1468
PAI Holdings LLC dba PAI Pharma lidocaine and prilocaine 0121-1002
E Fougera & Co a division of Fougera Pharmaceuticals Inc lidocaine and prilocaine 0168-0357
Padagis US LLC lidocaine and prilocaine 0574-2042
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM METABISULFITE

lidocaine drug variants containing SODIUM METABISULFITE

Company Ingredient NDC
B Braun Medical Inc lidocaine hcl and epinephrine 0264-9378
Henry Schein Inc lidocaine hydrochloride and epinephrine 0404-9788
Henry Schein Inc lidocaine hydrochloride and epinephrine 0404-9792
Henry Schein Inc lidocaine hydrochloride and epinephrine 0404-9886
Hospira Inc lidocaine hydrochloride and epinephrine 0409-1209
A-S Medication Solutions lidocaine hydrochloride,epinephrine bitartrate 50090-3321
A-S Medication Solutions lidocaine hydrochloride,epinephrine bitartrate 50090-6851
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM POLYACRYLATE

Excipient focus: SODIUM SACCHARIN

Excipient focus: SORBITAN MONOPALMITATE

lidocaine drug variants containing SORBITAN MONOPALMITATE

Company Ingredient NDC
Galen US Incorporated lidocaine and tetracaine 10885-002
Taro Pharmaceuticals USA Inc lidocaine and tetracaine 51672-5305
SAE LLC lidocaine and tetracaine 69420-3077
IPG PHARMACEUTICALS INC lidocaine and tetracaine 71085-100
Innovida Pharmaceutique Corporation lidocaine and tetracaine 71800-631
Oba Pharmaceuticals Inc lidocaine and tetracaine 73575-009
Oba Pharmaceuticals Inc lidocaine and tetracaine 73575-010
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SORBITOL

Excipient focus: STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER

Excipient focus: TARTARIC ACID

Excipient focus: TERPENE RESIN

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: UREA

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links